|
Chemotherapy is the use of anti-cancer drugs, which are
usually given into a vein. The drugs enter the bloodstream and
circulate throughout the body to reach and destroy cancer cells. This
makes chemotherapy useful for treating neuroblastoma that has spread to
the lymph nodes, bone marrow, liver, lungs, or other organs.
Some cases of neuroblastoma are treated with chemotherapy
given along with surgery, either before (neoadjuvant chemotherapy) or
after (adjuvant chemotherapy). In other cases, especially when the
cancer has spread too far to be completely removed by surgery,
chemotherapy is the main treatment.
Most children with neuroblastoma will need to have
chemotherapy. In most cases, a combination of medicines are given. The
main drugs used to treat children with neuroblastoma include:
- Cyclophosphamide or ifosfamide
- Cisplatin or carboplatin
- Vincristine
- Doxorubicin (Adriamycin)
- Etoposide
- Topotecan
The most common combination of drugs to treat neuroblastoma
consists of carboplatin (or cisplatin), cyclophosphamide, doxorubicin,
and etoposide, but others may be used. For children in the high-risk
group, larger combinations of drugs are used, and the drugs are given
at higher doses, which may be followed by a stem cell transplant (see
below).
Possible side effects of chemotherapy
Chemotherapy drugs work by attacking cells that are dividing
quickly, which is why they work against cancer cells. But other cells
in the body, such as those in the bone marrow, the lining of the mouth
and intestines, and the hair follicles, also divide quickly. These
cells are also likely to be affected by chemotherapy, which can lead to
side effects.
Children seem to have an advantage over adults when it comes
to chemotherapy. They tend to have less severe side effects and recover
from side effects more quickly. One benefit of this is that doctors can
give high doses of chemotherapy that are necessary to kill the tumor.
The side effects of chemotherapy depend on the type and dose
of drugs given and the length of time they are taken. General side
effects of chemotherapy drugs can include:
- Hair loss
- Mouth sores
- Loss of appetite
- Nausea and vomiting
- Increased chance of infections (due to low white blood cell
counts)
- Easy bruising or bleeding (due to low blood platelet
counts)
- Fatigue (due to low red blood cell counts)
Most of these side effects are short-term and tend to go away
after treatment is finished. There are often ways to lessen these side
effects. For example, drugs can be given to help prevent or reduce
nausea and vomiting. Be sure to discuss any questions you have about
side effects with the cancer care team.
Along with the effects listed above, some side effects are
specific to certain medicines:
Cyclophosphamide and ifosfamide can damage the bladder. This
can be avoided or minimized by giving the drugs with plenty of fluids
and with a drug called mesna, which helps protect the bladder. These
drugs can also damage the ovaries or testicles and may affect fertility
(the ability to have children).
Doxorubicin can cause heart damage. Doctors try to reduce this
risk as much as possible by not giving more than the recommended doses
of doxorubicin and by checking the heart with a test called an
echocardiogram (an ultrasound of the heart) during treatment. This drug
can also cause skin damage if it should leak out of the vein during
administration.
Cisplatin and carboplatin can affect the kidneys. Giving
plenty of fluids can help reduce this risk. These drugs can also affect
hearing in some cases. Your child's doctor may check this with hearing
tests (audiograms) during or after treatment.
Vincristine can damage nerves. Some patients may notice
tingling and numbness, particularly in the hands and feet.
Chemotherapy may also have longer-term side effects in some
cases. For example, some drugs used to treat neuroblastoma can increase
the risk of later developing a cancer of white blood cells known as
acute myeloid leukemia (AML). While this is a serious risk, it is not
common, and the importance of chemotherapy in treating neuroblastoma
far outweighs this risk. For more on the possible long-term effects of
treatment, see the section, "What
happens after treatment for neuroblastoma?"
Last Medical Review: 11/23/2009 Last Revised: 11/23/2009
|